Dioxethedrin

Dioxethedrin
Clinical data
Other names	Dioxethedrine; 3,4-Dihydroxy-N-ethylnorephedrine; 3,4,β-Trihydroxy-N-ethyl-α-methyl-β-phenethylamine; 3,4,β-Trihydroxy-N-ethylamphetamine; α-Methyl-N-ethylnorepinephrine
Identifiers
	IUPAC name 4-[2-(ethylamino)-1-hydroxypropyl]benzene-1,2-diol;
CAS Number	497-75-6 ;
PubChem CID	71632 ;
ChemSpider	64697 ;
UNII	82J92E653W ;
ChEBI	CHEBI:134881 ;
ChEMBL	ChEMBL2110629 ;
CompTox Dashboard (EPA)	DTXSID00862044 ;
ECHA InfoCard	100.007.137
Chemical and physical data
Formula	C11H17NO3
Molar mass	211.261 g·mol−1
3D model (JSmol)	Interactive image ;
	SMILES CCNC(C)C(C1=CC(=C(C=C1)O)O)O;
	InChI InChI=1S/C11H17NO3/c1-3-12-7(2)11(15)8-4-5-9(13)10(14)6-8/h4-7,11-15H,3H2,1-2H3; Key:OHDICGSRVLBVLC-UHFFFAOYSA-N;

Last updated October 10, 2025

Dioxethedrin (INN Tooltip International Nonproprietary Name), or dioxethedrine, also known as 3,4-dihydroxy-N-ethylnorephedrine, is a sympathomimetic medication.^[1]^[2]^[3] It was a component of the antitussive syrup Bexol (a combination of dioxethedrin, codeine, and promethazine).^[4]^[5] It is an ephedrine derivative (and hence is a phenethylamine and amphetamine) and is described as a bronchodilator and β-adrenergic receptor agonist.^[2]^[4] Analogues of dioxethedrin include dioxifedrine (α-methylepinephrine; 3,4-dihydroxyephedrine), corbadrine (levonordefrin; α-methylnorepinephrine), and α-methyldopamine.^[1]

References

1 2 Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 444. ISBN 978-1-4757-2085-3 . Retrieved 1 September 2024.
1 2 Milne GW (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. p. 494. ISBN 978-1-351-78990-5 . Retrieved 1 September 2024.
↑ Pschyrembel W, Dornblüth O, Zink C (2012). "Dioxethedrin". Pschyrembel klinisches Wörterbuch: Mit klinischen Syndromen und Nomina Anatomica (in German). De Gruyter. p. 358. ISBN 978-3-11-150689-0 . Retrieved 1 September 2024.
1 2 "Dioxethedrin Hydrochloride". Inxight Drugs. Retrieved 1 September 2024.
↑ Portmann M, Delage R (1964). "[The Antitussive Combination Dioxethedrine-Codeine-Promethazine]". Revue de Laryngologie - Otologie - Rhinologie (in French). 85: 1073–1081. PMID 14266725.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[Elks2014-1] 1 2 Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 444. ISBN 978-1-4757-2085-3 . Retrieved 1 September 2024.

[Milne2018-2] 1 2 Milne GW (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. p. 494. ISBN 978-1-351-78990-5 . Retrieved 1 September 2024.

[PschyrembelDornblüthZink2012-3] Pschyrembel W, Dornblüth O, Zink C (2012). "Dioxethedrin". Pschyrembel klinisches Wörterbuch: Mit klinischen Syndromen und Nomina Anatomica (in German). De Gruyter. p. 358. ISBN 978-3-11-150689-0 . Retrieved 1 September 2024.

[InxightDrugs-4] 1 2 "Dioxethedrin Hydrochloride". Inxight Drugs. Retrieved 1 September 2024.

[PortmannDelage1964-5] Portmann M, Delage R (1964). "[The Antitussive Combination Dioxethedrine-Codeine-Promethazine]". Revue de Laryngologie - Otologie - Rhinologie (in French). 85: 1073–1081. PMID 14266725.

[1]

[2]

[3]

[4]

[5]